Global Pneumonia Testing Market to Grow at a CAGR of 9.91% by 2021 - Growing Consumer Shift Toward Direct-to-Consumer Testing - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Pneumonia Testing Market 2017-2021" report to their offering.

The global pneumonia testing market to grow at a CAGR of 9.91% during the period 2017-2021.

The report, Global Pneumonia Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

According to the report, one driver in market is growing popularity of POC testing. POC testing is the new boom in the market because of the decreased time latency between diagnosis and treatment. The advances in POC technology have facilitated data storage, data sharing, and communication with public health agencies. Performing these tests to screen infectious diseases extends the applications of this technology to the community practice setting. For instance, processing accurate data on the prevalence of pneumonia in a community could help restrain inappropriate use of antibiotics and improve the allocation of vaccines to areas with the highest need.

Key vendors

  • Abbott Molecular
  • bioMérieux
  • Becton, Dickenson and Company (BD)
  • Roche Molecular Diagnostics
  • Thermo Fisher Scientific

Other Prominent Vendors

  • AdvanDx
  • Alere
  • Beckman Coulter
  • Bio-Rad
  • Cepheid
  • Concile
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Others

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by product type

PART 07: Market segmentation by method

PART 08: Market segmentation by technology

PART 10: Geographical segmentation

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape

PART 17: Key vendor analysis

PART 18: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/2j9zq2/global_pneumonia

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Disease Testing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Disease Testing